Skip to main content
. 2020 Sep 18;15(9):e0239329. doi: 10.1371/journal.pone.0239329

Fig 3.

Fig 3

Euro-NMD centers strategies for reporting variants of uncertain significance (VOUS) and incidental findings and for validating NGS variants: a) centre’s approach to VOUS; b) centre’s approach to incidental findings; c) use of Sanger sequencing validation of NGS identified variants.